LYVE1 Mouse Sf9

Lymphatic Vessel Endothelial Hyaluronic Acid Receptor 1 Mouse Recombinant, Sf9
Cat. No.
BT7577
Source
Insect Cells.
Synonyms
Lymphatic vessel endothelial hyaluronic acid receptor 1 precursor, LYVE-1, Cell surface retention sequence-binding protein 1, CRSBP-1, Hyaluronic acid receptor, Extracellular link domain-containing protein.
Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.
Purity
Greater than 95.0% as determined by:
(a)Analysis by RP-HPLC.
(b)Analysis by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Soluble LYVE1 Mouse Recombinant fused to a C-terminal His-tag (6xHis) produced in baculovirus is a monomeric, glycosylated, polypeptide containing 228 amino acids (Met-1 to Gly 228) and having a molecular mass of 25 kDa but as a result of glycosilation the Mw is 40 kDa.
The LYVE-1 is purified by proprietary chromatographic techniques.

Product Specs

Introduction
LYVE-1, a primary receptor for hyaluronan (HA), is found on lymphatic vessel walls. This receptor plays a crucial role in HA binding within the lymphatic system. Sequence analysis reveals that LYVE-1 is a type I integral membrane polypeptide consisting of 322 amino acids. It shares a 41% similarity with CD44, another HA receptor. The extracellular domain of LYVE-1, spanning 212 residues, contains a single Link module, which is a characteristic HA-binding domain found in the Link protein superfamily. Both LYVE-1 and CD44 can bind to soluble and immobilized HA. However, LYVE-1 is exclusively localized on the inner surface of lymph vessels and is not present in blood vessels. This unique distribution pattern distinguishes LYVE-1 as a specific marker for lymphatic vessels.
Description
Recombinant soluble LYVE1 from mouse, fused with a C-terminal His-tag (6xHis), is produced in baculovirus. This monomeric glycoprotein has a molecular weight of 25 kDa based on its 228 amino acid sequence (Met-1 to Gly 228). However, due to glycosylation, the apparent molecular weight is 40 kDa. The purification of LYVE-1 is achieved through proprietary chromatographic methods.
Physical Appearance
White, lyophilized powder, sterile filtered.
Formulation
The lyophilized LYVE1 was prepared from a sterile solution at a concentration of 1mg/ml. The solution does not contain any additives.
Solubility
To reconstitute the lyophilized LYVE1, it is recommended to dissolve it in sterile water to a concentration of at least 100µg/ml. Further dilutions can be made using other aqueous solutions.
Stability
Lyophilized sLYVE-1 remains stable for 3 weeks at room temperature. However, it is recommended to store it desiccated at a temperature below -18°C. After reconstitution, sLYVE-1 should be stored at 4°C for a period of 2-7 days. For long-term storage, it is recommended to store it at -18°C. To ensure stability during long-term storage, it is advisable to add a carrier protein (0.1% HSA or BSA). It is important to avoid repeated freeze-thaw cycles.
Purity
The purity is determined to be greater than 95.0% using the following methods:
(a) RP-HPLC analysis.
(b) SDS-PAGE analysis.
Synonyms
Lymphatic vessel endothelial hyaluronic acid receptor 1 precursor, LYVE-1, Cell surface retention sequence-binding protein 1, CRSBP-1, Hyaluronic acid receptor, Extracellular link domain-containing protein.
Source
Insect Cells.

Product Science Overview

Gene and Protein Structure

The LYVE1 gene encodes a protein that consists of 228 amino acids and has a molecular mass of approximately 25 kDa. However, due to glycosylation, the molecular weight can increase to around 40 kDa . The protein is characterized by its ability to bind both soluble and immobilized hyaluronan, which is a significant component of the extracellular matrix .

Function and Role

LYVE1 plays a crucial role in the transport of hyaluronan within the lymphatic system. It may function either by mediating the uptake of hyaluronan for catabolism within lymphatic endothelial cells or by transporting it into the lumen of afferent lymphatic vessels for subsequent re-uptake and degradation in lymph nodes . This receptor is also involved in the autocrine regulation of cell growth mediated by growth regulators containing cell surface retention sequence binding (CRS) .

Expression and Localization

LYVE1 is predominantly expressed on the surface of lymphatic endothelial cells and serves as a marker for these cells. Its expression is not restricted to lymphatic vessels but is also observed in normal liver blood sinusoids and embryonic blood vessels . Additionally, LYVE1-positive macrophages have been identified in various tissues, including the meninges of rats .

Clinical Significance

The LYVE1 protein has been implicated in several physiological and pathological processes. It is known to play a role in lymphangiogenesis, which is the formation of new lymphatic vessels from pre-existing ones. This process is crucial for maintaining fluid balance and immune function. Moreover, LYVE1 has been associated with tumor metastasis, as it may facilitate the transport of cancer cells through the lymphatic system .

Recombinant LYVE1 (Mouse, Sf9)

The recombinant form of LYVE1, produced in Sf9 insect cells, is often used in research to study its function and interactions. This recombinant protein is typically fused to a C-terminal His-tag (6xHis) to facilitate purification and detection. The recombinant LYVE1 retains its ability to bind hyaluronic acid and is used in various assays to investigate its role in lymphatic biology and disease .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.